Identifying factors associated with clinical success in patients treated with NASHA(®)/Dx injection for fecal incontinence

PURPOSE: Injection with the bulking agent consisting of non-animal stabilized hyaluronic acid/dextranomer (NASHA(®)/Dx) is well tolerated and efficacious for the treatment of fecal incontinence (FI); however, the patient population that may derive maximum benefit has not been established. This post...

Descripción completa

Detalles Bibliográficos
Autores principales: Franklin, Howard, Barrett, Andrew C, Wolf, Ray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Post Hoc Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780737/
https://www.ncbi.nlm.nih.gov/pubmed/27042136
http://dx.doi.org/10.2147/CEG.S95238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780737/
https://www.ncbi.nlm.nih.gov/pubmed/27042136
http://dx.doi.org/10.2147/CEG.S95238

Ejemplares similares